UroGen Pharma Ltd. (URGN)

Healthcare · Biotechnology · NASDAQ

UroGen Pharma Ltd. (URGN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.29B and a free-cash-flow yield of -7.2%. Over the most recent reported fiscal year, revenue grew 21.4%.

Market cap	$2.29B
Trailing P/E	—
FCF yield	-7.2%
Revenue growth (YoY)	+21.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live URGN data on Nama Insights →